Progressive Care Doubles March Sales, Successfully Utilizing Its Market Leading Contactless RX Delivery Due to Covid-19 Pandemic
MIAMI, FL– April 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased toannounce operational performance data for March 2020, which featured breakthrough growth in total sales and a new Company record in total number of prescriptions filled on sharp market share gains:
· Consolidated monthly gross sales across all locations totaled $3.6 million, representing year-over-year growth of 105%compared to March 2019,
· Prescriptions filled during the month came in at 47,467, representing year-over-year growth of 76% compared to March 2019,
· Prescriptions filled hit a new all-time monthly record for the Company in March,
· “Ready, Set, PrEP” Program for HIV prevention launched,
· Seeing continued growth in services targeting non-profit organizations,
· Will file with SEC for fully reporting status.
“Our market-leading contactless delivery experience has positioned Progressive Care to truly thrive in this uniquely challenging context, and that really showed through in March,” commented S.Parikh Mars, CEO of Progressive Care. “Much of this growth is the result of patients and physicians choosing our pharmacies over grocery store and chain pharmacies to better protect themselves from exposure during this time. We have worked steadily to deliver prescriptions securely while adhering to contactless protocols during the pandemic.”
Management notes that March was a record-breaking month driven largely by heavy incentivization at the prescriber level to recommend pharmacy services that minimize the risk of patient infections. Progressive Care has earned a reputation in the physician community for safeguarding the health and well being of patients.
The Company believes that this explosive wave of growth is best understood as a market share phenomenon, which is a dynamic that may continue to define results over the intermediate term. The Company expects continued influxes of new patients over the next 30 days as patients are encouraged to stay at home. Furthermore, it does not expect added attrition of patients once the current crisis conditions wain as patients of the Company have high satisfaction rates.
“We have also launched our Ready, Set, PrEP Program for HIV prevention, and we have worked steadily to add new relationships with not-for-profit clinics,” continued Mars. “We expect to haveseveral of these clinics actively engaged with this service in Q3.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
ProgressiveCare Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,LLC
https://www.facebook.com/pharmcorx/
FiveStar RX
https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27 A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,”“upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
